top of page

Transforming
UTERINE HEALTH

through intrauterine treatments

Screenshot 2025-06-12 13.19.40-Photoroom.png
Screenshot 2025-06-12 13.16.37-Photoroom.png

Our treatments

Screenshot 2025-06-12 14.40.55.png

Womed has developed Womed Leaf®, a treatment for women whose uterus is scarred and subject to repeated miscarriages.

Screenshot 2025-06-12 14.51.34.png

Womed is developing a low dose, targeted, intrauterine effective treatment to reduce abnormal bleeding associated with fibroids.

Screenshot 2025-06-12 14.56.24.png

Womed is developing a new intrauterine drug delivery system to alleviate the tremendous suffering of women with endometriosis and help them lead a normal life.

Screenshot 2025-06-12 14.42.42.png

Womed is developing a rapid and effective treatment for women presenting to the emergency suite with acute uterine bleeding.

Latest news

US FDA Approves First Medical Device For Women With Asherman Syndrome

The Food and Drug Administration approved the PreMarket Approval (PMA) application of the Womed Leaf® for adult women undergoing hysteroscopic surgery for symptomatic moderate to severe intrauterine adhesions, also referred to as Asherman syndrome. Womed Leaf® is the first medical device to be approved for sale in the United States for that indication.

​

bottom of page